EU Court Adviser Sides With German Drugmaker In VAT Fight
German drugmakers may be able to include price rebates while calculating value-added tax on sales to private health insurers, just as they can for public health insurance funds, after a European...To view the full article, register now.
Already a subscriber? Click here to view full article